Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5694  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
  »   Search
  »   Current Issue
  »   Submit Article 
  »   My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl,Gagandeep Kaur,Ovidiu Fratila,Camelia Buhas,Claudia Teodora Judea-Pusta,Nicoleta Negrut,Cristiana Bustea,Simona Bungau
Translational Neurodegeneration.2021;10(1)
[DOI]
2Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Rahul Saxena,Gladys Rai
Translational Neurodegeneration.2020;10(1)47
[DOI]
3Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy
Rongbo Zhang,Jing Li,You Wu,Shunli Liang,Linsheng Xu
Genetic Testing and Molecular Biomarkers.2021;25(1)20
[DOI]
4Nörodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli
Cem HAZIR,Gamze BORA,Hayat Erdem YURTER
Uludag Üniversitesi Tip Fakültesi Dergisi.2020;25(1)20
[DOI]
5Nörodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli
Trisha Bhatt,Bhoomika M. Patel,Mayur M. Patel
Uludag Üniversitesi Tip Fakültesi Dergisi.2021;25(1)491
[DOI]
6Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease – In vitro & In vivo model
Jinwei Xue,Tongtong Liu,Yongdan Liu,Ye Jiang,Vidya Devanatha Desikan Seshadri,Surapaneni Krishna Mohan,Li Ling
Journal of Photochemistry and Photobiology B: Biology.2019;200(1)111635
[DOI]
7Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease – In vitro & In vivo model
Luciana Auxiliadora de Paula Vasconcelos
Journal of Photochemistry and Photobiology B: Biology.2020;200(1)111635
[DOI]
8Orally Administered Nanotherapeutics For Parkinson’s Disease: An Old Delivery System Yet More Acceptable
Nidhi Aggarwal,Zufika Qamar,Saleha Rehman,Sanjula Baboota,Javed Ali
Current Pharmaceutical Design.2020;26(19)2280
[DOI]
9The potential role of metformin in the treatment of Parkinson's disease
Mengnan Lu,Huangtao Chen,Fayi Nie,Xinyi Wei,Zhiwei Tao,Jie Ma
Journal of Bio-X Research.2020;3(1)27
[DOI]
10Curcumin and neurological diseases
Raffaella Adami,Daniele Bottai
Nutritional Neuroscience.2020;3(1)1
[DOI]
11Impulse control disorders in Parkinson's disease: A systematic review on risk factors and pathophysiology
Desiree Latella,Maria Grazia Maggio,Giuseppa Maresca,Anna Federica Saporoso,Maria Le Cause,Alfredo Manuli,Demetrio Milardi,Placido Bramanti,Rosaria De Luca,Rocco Salvatore Calabrň
Journal of the Neurological Sciences.2019;398(1)101
[DOI]
12Natural Approaches for Neurological Disorders—The Neuroprotective Potential of Codium tomentosum
Joana Silva,Alice Martins,Celso Alves,Susete Pinteus,Helena Gaspar,Amparo Alfonso,Rui Pedrosa
Molecules.2020;25(22)5478
[DOI]
13Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
Vinod Metta,Rupam Borgohain,Prashanth L Kukkle,Rukmini Mridula,Pankaj Agarwal,Asha Kishore,Vinay Goyal,Ray Chaudhuri
Annals of Movement Disorders.2020;3(3)145
[DOI]
14An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry
Abdul Waheed Khan,Arif-ullah Khan,Syed Muhammad Mukarram Shah,Aziz Ullah,Muhammad Faheem,Muhammad Saleem
Evidence-Based Complementary and Alternative Medicine.2019;2019(3)1
[DOI]
15Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
Tapan Behl,Gagandeep Kaur,Simona Bungau,Rishabh Jhanji,Arun Kumar,Vineet Mehta,Gokhan Zengin,Roxana Brata,Syed Shams ul Hassan,Ovidiu Fratila
International Journal of Molecular Sciences.2020;21(17)6235
[DOI]
16Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
Siyan Zhang,Kai Tao,Jia Wang,Yunyou Duan,Bao Wang,Xi Liu
Frontiers in Cellular Neuroscience.2020;14(17)6235
[DOI]
17Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
Inez A. Flameling,Ger T. Rijkers
Frontiers in Cellular Neuroscience.2018;14(17)6235
[DOI]
18Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
Parisa Dehghani,Vahid Jahed,Ali Zarrabi
Frontiers in Cellular Neuroscience.2020;14(17)1
[DOI]
19Effects of domotics on cognitive, social and personal functioning in patients with Parkinson’s disease: a pilot study.
Desiree Latella,Maria Grazia Maggio,Giuseppa Maresca,Adriana Andaloro,Smeralda Anchesi,Valentina Pajno,Rosaria De Luca,Giuseppe Di Lorenzo,Alfredo Manuli,Rocco Salvatore Calabrň
Assistive Technology.2020;14(17)1
[DOI]
20Mutational Impact on “in-Between-Ring” (IBR) Domain of PARKIN on Protein Stability and Function
Sima Biswas,Angshuman Bagchi
Applied Biochemistry and Biotechnology.2021;14(17)1
[DOI]
21Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinson’s Disease
Jagatheesh Kaliaperumal,Satguru Dulari,Pandurangan A.,Mahendra Singh Rathore,Amit Mittal,Md. Shamshir Alam
Journal of Evolution of Medical and Dental Sciences.2020;9(34)2466
[DOI]
22Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chen-hong Guo,Ting Cao,Long-tai Zheng,John L Waddington,Xue-chu Zhen
Acta Pharmacologica Sinica.2020;41(4)499
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow